Loading...
healthfitnessmedicine
Caveat emptor when it comes to hormone therapy for menopause, Elizabeth Tracey reports
About this Episode
Hormone therapy for menopause has recently had a black box warning removed by the FDA, after the agency reexamined data originally prompting the warning and found it flawed. Wen Shen, a menopause expert at Johns Hopkins, says women still need …
Caveat emptor when it comes to hormone therapy for menopause, Elizabeth Tracey reports Read More »
Hosts & Guests
No transcript available for this episode.
More from Health Newsfeed – Johns Hopkins Medicine Podcasts
View all episodes →
Increasing rates of obesity and severe obesity may presage increased rates of he...
Health Newsfeed – Johns Hopkins Medicine Podcasts
Apr 23, 20261:06failed
Is there another benefit besides weight loss of GLP-1s in people with severe obe...
Health Newsfeed – Johns Hopkins Medicine Podcasts
Apr 23, 20261:04failed